비교리스트

 카트 문의
시장보고서
상품코드
1511874

정맥 영양 시장 규모, 점유율, 동향 분석 리포트 : 영양 유형별, 단계 유형별, 적응증별, 판매채널별, 지역별, 부문별 예측(2024-2030년)

Parenteral Nutrition Market Size, Share & Trends Analysis Report By Nutrient Type (Carbohydrates, Parenteral Lipid Emulsion), By Stage Type, By Indication, By Sales Channel, By Region, And Segment Forecasts, 2024 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 125 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

정맥 영양 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 정맥 영양 시장 규모는 2030년까지 106억 8,000만 달러에 달하며, 2024-2030년의 CAGR은 6.01%를 기록할 것으로 예측됩니다.

영양실조 유병률 증가, 대사성 질환 증가, 노인 인구 증가, 의료 인프라의 발전은 시장 성장을 가속하는 요인 중 일부입니다. 노인 인구 증가는 정맥영양(PN) 수요 증가에 크게 기여하고 있습니다. 예를 들어 인구문제연구소(PRB)에 따르면 미국의 65세 이상 인구는 2022년 5,800만 명에서 2050년 8,200만 명으로 증가할 것으로 예상됩니다.

면역력이 약하고 신경질환, 심혈관질환, 암, 척추 손상에 취약한 노인 인구가 많다는 점은 시장 성장 촉진요인으로 큰 영향을 미치고 있습니다. 또한 중증 환자의 필수 영양 부족이 급증하고 병원 관련 영양실조에 대한 인식이 높아지는 것도 PN 채택을 증가시키는 몇 가지 중요한 요인입니다. 비경구 약물 투여는 빠른 효과와 저용량 전달의 이점을 제공하고 식단 불균형으로 인한 다양한 부작용을 예방할 수 있으며, 시장 성장을 가속할 것으로 예상됩니다. 그러나 투여 중 감염 위험이 높고 환자들 사이에서 정맥 영양에 대한 선호도가 높아지면서 시장 성장을 저해하는 주요 요인으로 작용하고 있습니다. 전 세계 인구 증가로 인해 의료 비용과 가정내 식료품 비용이 증가하고 있습니다.

따라서 출산율 증가는 영양 수준에 영향을 미쳐 시장 성장을 가속할 것으로 예상됩니다. 유엔 통계에 따르면 세계 인구는 2022년 80억 명에서 2050년 97억 명, 1980년대 중반에는 104억 명으로 증가할 것으로 예상됩니다. 이러한 인구 증가는 영양 성분의 희소성을 높이고 시장 성장을 가속할 수 있습니다. 실현된 출산율은 출생아 1인당 물, 식량, 투약의 필요량 등 환경뿐만 아니라 자원에 대한 압박을 포함하기 때문에 절대 출산율(조출생률)보다 더 중요한 역할을 합니다. 실현 출산율은 지난 10년간 증가하며 왔으며, 이러한 추세는 예측 기간 중 지속될 것으로 예상되며, 2020년 미국 국립보건통계센터(NCHS)가 보고한 출산율은 인구 1,000명당 11.99명이었습니다. 또한 저체중아 비율은 8.0%로 전 세계에서 PN 제품에 대한 수요가 증가하고 있습니다.

정맥영양 시장 보고서 하이라이트

영양 유형에 따라 시장은 탄수화물, 비경구 지질 에멀젼, 단일 용량 아미노산 용액, 미량 원소, 비타민 및 미네랄로 분류됩니다. 단일 용량 아미노산 부문은 모든 연령대에 적합하고 다른 유형의 정맥 영양에 비해 부작용이 적기 때문에 2023년 30.7%의 가장 큰 매출 점유율을 차지할 것으로 예상됩니다.

단계별로는 노인 인구가 암, 당뇨병, 알츠하이머병 등 다양한 만성질환에 취약한 탓에 성인 시장이 2023년 87.1%의 매출 점유율을 차지할 것으로 예상됩니다.

시설 판매 채널은 2023년 48.1%의 최대 매출 점유율로 시장을 장악했습니다. 반면, 온라인 채널은 예측 기간 중 가장 빠른 성장률을 보일 것으로 예상됩니다.

2023년에는 북미가 41.5%로 가장 큰 매출 점유율을 차지할 것으로 예상되며, 아시아태평양은 의료비 지출 증가, 의료 인프라 개선, 1인당 소득 증가, 조산율 증가로 인해 가장 빠른 성장세를 보일 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 정맥 영양 시장 변수, 동향, 범위

  • 시장 계통 전망
    • 모시장 전망
    • 관련/보조 시장 전망
  • 업계 분석
    • 사용자의 시점 분석
    • 주요 최종사용자
  • 테크놀러지 전망
  • 규제 프레임워크
  • 시장 역학
    • 시장 촉진요인 분석
    • 시장 억제요인 분석
    • 업계의 과제와 기회의 분석
  • 정맥 영양 시장 분석 툴
    • Porter의 산업 분석
    • PESTEL 분석
  • 정맥 영양 업계에서 주요 거래와 전략적 제휴의 분석
  • COVID-19의 영향

제4장 정맥 영양 시장 : 영양 유형 추정·동향 분석

  • 정의와 범위
  • 영양 유형의 시장 점유율 분석, 2023년 및 2030년
  • 부문 대시보드
  • 정맥 영양 시장 : 영양 유형별, 2018-2030년
  • 탄수화물
  • 비경구 지질 유제
  • 일회 투여 아미노산 용액
  • 미량원소
  • 비타민과 미네랄

제5장 정맥 영양 시장 : 단계 유형 추정·동향 분석

  • 정의와 범위
  • 단계 유형의 시장 점유율 분석, 2023년 및 2030년
  • 부문 대시보드
  • 정맥 영양 시장 : 단계 유형별, 2018-2030년
  • 성인
  • 소아

제6장 정맥 영양 시장 : 적응증 추정·동향 분석

  • 정의와 범위
  • 적응증의 시장 점유율 분석, 2023년 및 2030년
  • 부문 대시보드
  • 정맥 영양 시장 : 적응증별, 2018-2030년
  • 소아 알츠하이머병
  • 영양 부족
  • 암치료
  • 당뇨병
  • 만성신장병
  • 희귀질환
  • 연하장애
  • 통증 관리
  • 흡수 불량/위장 장애/설사
  • 기타

제7장 정맥 영양 시장 : 판매채널 추정·동향 분석

  • 정의와 범위
  • 판매채널의 시장 점유율 분석, 2023년 및 2030년
  • 부문 대시보드
  • 정맥 영양 시장 : 판매채널별, 2018-2030년
  • 온라인
  • 소매
  • 기관

제8장 정맥 영양 시장 : 국, 영양소 유형, 단계의 유형, 적응증, 판매채널별 지역 추정·동향 분석

  • 정의와 범위
  • 지역 시장 점유율 분석, 2023년 및 2030년
  • 지역 시장 대시보드
  • 지역 시장 스냅숏
  • SWOT 분석
  • 정맥 영양 시장 점유율, 지역별, 2023년 및 2030년
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제9장 경쟁 구도

  • 주요 시장 참여 기업별 최근 동향과 영향 분석
  • 기업 분류
  • 기업의 시장 점유율 분석
  • 기업 히트맵 분석
  • 전략 매핑
    • 확대
    • 합병과 인수
    • 파트너십과 협업
    • 신제품의 발매
    • 연구개발
  • 기업 개요
    • Baxter
    • Allergan
    • Actavis Inc.
    • Otsuka Pharmaceutical Factory, Inc.
    • Grifols, SA
    • B. Braun Melsungen AG
    • Vifor Pharma
    • Fresenius Kabi AG
    • Sichuan Kelun Pharmaceutical Co., Ltd
    • Pfizer Inc.(Hospira Inc.)
KSA 24.07.16

Parenteral Nutrition Market Growth & Trends:

The global parenteral nutrition market size is expected to reach USD 10.68 billion by 2030, registering a CAGR of 6.01% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of malnutrition, rising metabolic disorders, growing geriatric population, and advancement in healthcare infrastructure are some of the factors driving the market growth. The rising geriatric population has significantly contributed to the increasing demand for parenteral nutrition (PN) as the elderly population is more vulnerable to several diseases. For instance, according to the Population Reference Bureau (PRB), the population of the U.S. aged above 65 years is expected to increase from 58 million in 2022 to 82 million in 2050.

The presence of a large pool of geriatric population with low immunity levels and susceptibility to neurological diseases, cardiovascular disorders, cancer, and spinal injuries is a high-impact rendering driver of the market. Moreover, a surge in essential nutrition deficiency among critically ill patients; and growing awareness about hospital-related malnutrition are a few key factors increasing PN adoption. Parenteral drug administration provides the benefit of fast action and lower dose delivery, which prevent various adverse effects because of dietary imbalances, thereby promoting market growth. However, the high risk of infection during administration and the growing preference for enteral nutrition among patients are major factors restricting the market growth. The growing population worldwide has increased healthcare costs and household food expenditures.

Hence, a higher birth rate is expected to impact nutrition levels, thereby driving market growth. According to the United Nations statistics, the world population is expected to increase from 8 billion in 2022 to 9.7 billion in 2050 and 10.4 billion by the mid-2080s. This rising population can increase the scarcity of nutritional ingredients, fueling market growth. Realized natality plays a more prominent role than absolute natality (crude birth rate), as it includes environmental as well as resource pressures, such as water, food, and medication requirements per birth. Realized natality has been growing in the last decade and the trend is anticipated to continue over the forecast period. In 2020, the natality rate reported by the National Center for Health Statistics (NCHS) was 11.99 births per 1,000 population. Furthermore, the percentage of lower-weight infants was 8.0%, thereby boosting the demand for PN products worldwide.

key Request a free sample copy or view report summary: Parenteral Nutrition Market Report

Parenteral Nutrition Market Report Highlights:

Based on nutrient type, the market is segmented into carbohydrates, parenteral lipid emulsions, single-dose amino acid solution, trace elements, and vitamins & minerals. The single-dose amino acid segment held the largest revenue share of 30.7% in 2023 owing to its compatibility with all age groups and its lesser adverse effects compared to other types of parenteral nutrition

Based on stage, the adult segment dominated the market with a revenue share of 87.1% in 2023 owing to the vulnerability of the elderly population to various chronic conditions such as cancer, diabetes, and Alzheimer's disease

Institutional sales channel dominated the market with the largest revenue share of 48.1% in 2023. On the other hand, online channels are anticipated to exhibit the fastest growth rate over the forecast period

In 2023, North America held the largest revenue share of 41.5%, while Asia Pacific is expected to witness the fastest growth due to rising healthcare expenditure, improving healthcare infrastructure, growing per capita income, and high occurrence of preterm births

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Nutrition Type Outlook
    • 2.2.2. Stage Type Outlook
    • 2.2.3. Indication Outlook
    • 2.2.4. Sales Channel Outlook
  • 2.3. Competitive Insights

Chapter 3. Parenteral Nutrition Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Industry Analysis
    • 3.2.1. User Perspective Analysis
    • 3.2.2. Key End-users
  • 3.3. Technology Outlook
  • 3.4. Regulatory Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market Drivers Analysis
      • 3.5.1.1. Rising geriatric population
      • 3.5.1.2. Increasing natality rate
      • 3.5.1.3. Increasing incidence of cancer
      • 3.5.1.4. Growing number of premature births
      • 3.5.1.5. Increasing risk of malnutrition
    • 3.5.2. Market Restraints Analysis
      • 3.5.2.1. Shortage of parenteral nutrition products
      • 3.5.2.2. High risk of infections
    • 3.5.3. Industry Challenges and Opportunity Analysis
  • 3.6. Parenteral Nutrition Market Analysis Tools
    • 3.6.1. Porter's Analysis
      • 3.6.1.1. Bargaining power of the suppliers
      • 3.6.1.2. Bargaining power of the buyers
      • 3.6.1.3. Threats of substitution
      • 3.6.1.4. Threats from new entrants
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTEL Analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Economic and Social landscape
      • 3.6.2.3. Technological landscape
      • 3.6.2.4. Environmental landscape
      • 3.6.2.5. Legal landscape
  • 3.7. Major Deals & Strategic Alliances Analysis in the Parenteral Nutrition Industry
  • 3.8. Impact of COVID-19

Chapter 4. Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Nutrient Type Market Share Analysis, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Parenteral Nutrition Market: By Nutrient Type, 2018 to 2030
  • 4.5. Carbohydrates
    • 4.5.1. Carbohydrates Market Revenue Estimates and Forecasts, 2018 - 2030
  • 4.6. Parenteral Lipid Emulsion
    • 4.6.1. Parenteral Lipid Emulsion Market Revenue Estimates and Forecasts, 2018 - 2030
  • 4.7. Single Dose Amino Acid Solution
    • 4.7.1. Single Dose Amino Acid Solution Market Revenue Estimates and Forecasts, 2018 - 2030
  • 4.8. Trace Elements
    • 4.8.1. Trace Elements Market Revenue Estimates and Forecasts, 2018 - 2030
  • 4.9. Vitamins & Minerals
    • 4.9.1. Vitamins & Minerals Market Revenue Estimates and Forecasts, 2018 - 2030

Chapter 5. Parenteral Nutrition Market: Stage Type Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Stage Type Market Share Analysis, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Parenteral Nutrition Market: By Stage Type, 2018 to 2030
  • 5.5. Adult
    • 5.5.1. Adult Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Pediatric
    • 5.6.1. Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Parenteral Nutrition Market: Indication Estimates & Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. Indication Market Share Analysis, 2023 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Parenteral Nutrition Market: By Indication, 2018 to 2030
  • 6.5. Pediatrics Alzheimer's
    • 6.5.1. Alzheimer's Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Nutrition Deficiency
    • 6.6.1. Nutrition Deficiency Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Cancer Care
    • 6.7.1. Cancer Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8. Diabetes
    • 6.8.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.9. Chronic Kidney Disease
    • 6.9.1. Chronic Kidney Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.10. Orphan Diseases
    • 6.10.1. Orphan Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.11. Dysphagia
    • 6.11.1. Dysphagia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.12. Pain Management
    • 6.12.1. Pain Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.13. Malabsorption/GI.Disorder/Diarrhea
    • 6.13.1. Malabsorption/GI.Disorder/Diarrhea Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.14. Others
    • 6.14.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Parenteral Nutrition Market: Sales Channel Estimates & Trend Analysis

  • 7.1. Definition and Scope
  • 7.2. Sales Channel Market Share Analysis, 2023 & 2030
  • 7.3. Segment Dashboard
  • 7.4. Parenteral Nutrition Market: By Sales Channel, 2018 to 2030
  • 7.5. Online
    • 7.5.1. Online Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6. Retail
    • 7.6.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.7. Institutional
    • 7.7.1. Institutional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Parenteral Nutrition Market: Regional Estimates & Trend Analysis by Country, Nutrient Type, Stage Type, Indication and Sales Channel

  • 8.1. Definition and Scope
  • 8.2. Regional Market Share Analysis, 2023 & 2030
  • 8.3. Regional Market Dashboard
  • 8.4. Regional Market Snapshot
  • 8.5. SWOT Analysis
    • 8.5.1. North America
    • 8.5.2. Europe
    • 8.5.3. Asia Pacific
    • 8.5.4. Latin America
    • 8.5.5. Middle East & Africa
  • 8.6. Parenteral Nutrition Market Share, By Region, 2023 & 2030 (USD Billion)
  • 8.7. North America
    • 8.7.1. North America Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.7.2. U.S.
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. U.S. Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.7.3. Canada
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Canada Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.8. Europe
    • 8.8.1. Europe Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.2. UK
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. UK Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.3. Germany
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Germany Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.4. France
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. France Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.5. Italy
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. Italy Parenteral Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.6. Spain
      • 8.8.6.1. Key Country Dynamics
      • 8.8.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.6.3. Competitive Insights
      • 8.8.6.4. Spain Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.7. Sweden
      • 8.8.7.1. Key Country Dynamics
      • 8.8.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.7.3. Competitive Insights
      • 8.8.7.4. Sweden Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.8. Denmark
      • 8.8.8.1. Key Country Dynamics
      • 8.8.8.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.8.3. Competitive Insights
      • 8.8.8.4. Denmark Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.9. Norway
      • 8.8.9.1. Key Country Dynamics
      • 8.8.9.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.9.3. Competitive Insights
      • 8.8.9.4. Norway Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.9. Asia Pacific
    • 8.9.1. Asia Pacific Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.9.2. China
      • 8.9.2.1. Key Country Dynamics
      • 8.9.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.2.3. Competitive Insights
      • 8.9.2.4. China Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.9.3. Japan
      • 8.9.3.1. Key Country Dynamics
      • 8.9.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.3.3. Competitive Insights
      • 8.9.3.4. Japan Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.9.4. India
      • 8.9.4.1. Key Country Dynamics
      • 8.9.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.4.3. Competitive Insights
      • 8.9.4.4. India Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.9.5. South Korea
      • 8.9.5.1. Key Country Dynamics
      • 8.9.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.5.3. Competitive Insights
      • 8.9.5.4. South Korea Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.9.6. Australia
      • 8.9.6.1. Key Country Dynamics
      • 8.9.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.6.3. Competitive Insights
      • 8.9.6.4. Australia Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.9.7. Thailand
      • 8.9.7.1. Key Country Dynamics
      • 8.9.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.7.3. Competitive Insights
      • 8.9.7.4. Thailand Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.10. Latin America
    • 8.10.1. Latin America Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.10.2. Brazil
      • 8.10.2.1. Key Country Dynamics
      • 8.10.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.2.3. Competitive Insights
      • 8.10.2.4. Brazil Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.10.3. Mexico
      • 8.10.3.1. Key Country Dynamics
      • 8.10.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.3.3. Competitive Insights
      • 8.10.3.4. Mexico Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.10.4. Argentina
      • 8.10.4.1. Key Country Dynamics
      • 8.10.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.4.3. Competitive Insights
      • 8.10.4.4. Argentina Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.11. Middle East and Africa
    • 8.11.1. Middle East and Africa Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.11.2. Saudi Arabia
      • 8.11.2.1. Key Country Dynamics
      • 8.11.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.2.3. Competitive Insights
      • 8.11.2.4. Saudi Arabia Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.11.3. UAE
      • 8.11.3.1. Key Country Dynamics
      • 8.11.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.3.3. Competitive Insights
      • 8.11.3.4. UAE Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.11.4. South Africa
      • 8.11.4.1. Key Country Dynamics
      • 8.11.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.4.3. Competitive Insights
      • 8.11.4.4. South Africa Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.11.5. Kuwait
      • 8.11.5.1. Key Country Dynamics
      • 8.11.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.5.3. Competitive Insights
      • 8.11.5.4. Kuwait Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Market Share Analysis
  • 9.4. Company Heat Map Analysis
  • 9.5. Strategy Mapping
    • 9.5.1. Expansion
    • 9.5.2. Mergers & Acquisition
    • 9.5.3. Partnerships & Collaborations
    • 9.5.4. New Product Launches
    • 9.5.5. Research And Development
  • 9.6. Company Profiles
    • 9.6.1. Baxter
      • 9.6.1.1. Company Overview
      • 9.6.1.2. Financial Performance
      • 9.6.1.3. Product Benchmarking
      • 9.6.1.4. Strategic initiatives
    • 9.6.2. Allergan
      • 9.6.2.1. Company Overview
      • 9.6.2.2. Financial Performance
      • 9.6.2.3. Product Benchmarking
      • 9.6.2.4. Strategic initiatives
    • 9.6.3. Actavis Inc.
      • 9.6.3.1. Company Overview
      • 9.6.3.2. Financial Performance
      • 9.6.3.3. Product Benchmarking
      • 9.6.3.4. Strategic initiatives
    • 9.6.4. Otsuka Pharmaceutical Factory, Inc.
      • 9.6.4.1. Company Overview
      • 9.6.4.2. Financial Performance
      • 9.6.4.3. Product Benchmarking
      • 9.6.4.4. Strategic initiatives
    • 9.6.5. Grifols, S.A.
      • 9.6.5.1. Company Overview
      • 9.6.5.2. Financial Performance
      • 9.6.5.3. Product Benchmarking
      • 9.6.5.4. Strategic initiatives
    • 9.6.6. B. Braun Melsungen AG
      • 9.6.6.1. Company Overview
      • 9.6.6.2. Financial Performance
      • 9.6.6.3. Product Benchmarking
      • 9.6.6.4. Strategic initiatives
    • 9.6.7. Vifor Pharma
      • 9.6.7.1. Company Overview
      • 9.6.7.2. Financial Performance
      • 9.6.7.3. Product Benchmarking
      • 9.6.7.4. Strategic initiatives
    • 9.6.8. Fresenius Kabi AG
      • 9.6.8.1. Company Overview
      • 9.6.8.2. Financial Performance
      • 9.6.8.3. Product Benchmarking
      • 9.6.8.4. Strategic initiatives
    • 9.6.9. Sichuan Kelun Pharmaceutical Co., Ltd
      • 9.6.9.1. Company Overview
      • 9.6.9.2. Financial Performance
      • 9.6.9.3. Product Benchmarking
      • 9.6.9.4. Strategic initiatives
    • 9.6.10. Pfizer Inc. (Hospira Inc.)
      • 9.6.10.1. Company Overview
      • 9.6.10.2. Financial Performance
      • 9.6.10.3. Product Benchmarking
      • 9.6.10.4. Strategic initiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제